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Abstract Bone-marrow-derived mesenchymal stem
cells (MSCs) are multipotent cells capable of self-
renewal and differentiation into multiple cell types.
Accumulating preclinical and clinical evidence indi-
cates that MSCs are good candidates to use as cell
therapy in many degenerative diseases. For MSC
clinical applications, an adequate number of cells are
necessary so an extensive expansion is required.
However, spontaneous immortalization and malignant
transformation of MSCs after culture expansion have
been reported in human and mouse, while very few
data are present for rat MSCs (rMSCs). In this study,
we monitored the chromosomal status of rMSCs at
several passages in vitro, also testing the influence of
four different cell culture conditions. We first used the
conventional traditional cytogenetic techniques, in
order to have the opportunity to observe even minor
structural abnormalities and to identify low-degree
mosaic conditions. Then, a more detailed genomic
analysis was conducted by array comparative genomic
hybridization. We demonstrated that, irrespective of
culture conditions, rMSCs manifested a markedly
aneuploid karyotype and a progressive chromosomal
instability in all the passages we analyzed and that they
are anything but stable during in vitro culture. Despite
the fact that the risk of neoplastic transformation
associated with this genomic instability needs to be
further addressed and considering the apparent genomic
stability reported for in vitro cultured human MSCs
(hMSCs), our findings underline the fact that rMSCs
maynotinfactbeagoodmodelforeffectivelyexploring
the full clinical therapeutic potential of hMSCs.
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Introduction
Mesenchymal stem cells (MSCs) are a type of adult
stem cells residing mainly in the bone marrow, and a
precise definition of MSCs has been put forward by the
International Society for Cellular Therapy (Dominici et
al.2006). MSCs have several advantages over the other
potential stem cell candidates for cell therapy. MSCs
(1) can be easily isolated and expanded in vitro, (2)
can be used autologously, (3) are hypoimmuno-
genic and suitable for allogeneic transplantation, (4)
have immunoregulatory properties, (5) secrete a
broad spectrum of bioactive macromolecules, and
(6) have the capacity to migrate to the sites of
injury (Caplan 2007). Moreover, MSCs have the
capacity to differentiate into mesengenic lineages
(osteogenic, chondrogenic, and adipogenic lineages)
and to transdifferentiate into cells of nonmesodermal
origin such as hepatocytes (Lee et al. 2004)a n d
neural cells (Tondreau et al. 2008).
Several preclinical and clinical studies have
confirmed the great therapeutic potential of MSCs
(Brooke et al. 2007;C a p l a n2007;Y ua n dS i l v a
2008; Abdallah and Kassem 2009). For clinical
indications presently being tested, please see: http://
www.ClinicalTrials.gov/.
For MSCs’ clinicalapplications, anadequatenumber
of cells are necessary, and considering the low number
of MSCs (Wexler et al. 2003; Caplan 2007), an
extensive ex vivo expansion is required. The MSC
culture conditions are crucial in order to maintain
MSCs’ morphology and biological and functional
property intact for prolonged passages (Shahdadfar et
al. 2005;M e u l e m a ne ta l .2006; Neuhuber et al. 2008;
Pal et al. 2009). Fetal bovine serum (FBS) represents
the primary source of growth supplements and bioac-
tive compounds necessary for in vitro culture of MSCs,
and most research laboratories use media containing
10–20% FBS. For the optimization of MSC cultures,
various MSC culture conditions and different sources
of growth supplements other than FBS have recently
been evaluated (Doerr et al. 2003;M e u l e m a ne ta l .
2006; Sotiropoulou et al. 2006;M a n n e l l oa n dT o n t i
2007; Tonti and Mannello 2008; Pal et al. 2009).
Moreover, in long-term cultures, it is crucial to
evaluate the safety and quality of MSCs. A number of
papers have recently been published on chromosomal
stability and the spontaneous transformation of MSCs,
most of which are of human or mouse origin (Rubio et
al. 2005; Zhou et al. 2006; Aguilar et al. 2007;
Bernardo et al. 2007; Zhang et al. 2007; Meza-
Zepeda et al. 2008; Izadpanah et al. 2008;R ø s l a n de t
al. 2009). Very few data are present for rat MSCs
(rMSCs; Zhou et al. 2006; Furlani et al. 2009). The
importance of analyzing rMSCs is related to their use
as a model for understanding their human relatives. For
this purpose, we evaluated and compared the biological
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several culture passages/stages. In addition, for rMSCs,
we used four different cell culture conditions in order
to assess some possible influencing factors on genomic
stability. Firstly, we used the conventional, traditional
cytogenetic techniques in order to have the opportunity
to observe even minor structural abnormalities and to
identify low-degree mosaic conditions. Then, a more
detailed genomic analysis was conducted by array
comparative genomic hybridization (array-CGH).
Material and methods
Isolation and culture of rMSCs
Animal procedures were conducted in accordance
with the European Communities Council Directive
86/609/EEC. rMSCs were obtained from the bone
marrow of four 10-week-old female Sprague-Dawley
rats, as previously described (Donzelli et al. 2007).
Total cells extracted from bone marrow (P0) were
about 200×10
6. rMSCs were cultured in: α-minimum
essential medium (α-MEM) with 10% (a) or 20% (b)
embryonic stem cell screened fetal bovine serum (ES-
FBS) and Dulbecco’s modified Eagle medium
(DMEM) with 10% (c) or 20% (d) ES-FBS. rMSC
cultures were maintained at 37°C in a humidified
atmosphere containing 5% CO2. After 48 h, the
nonadherent cells were removed, and the cells
attaching to the culture flasks were cultured in the
four above conditions with a change of medium every
3–4 days. When rMSC cultures reached 80–90%,
cells were detached by using 0.25% trypsin in 0.1%
ethylenediaminetetraacetic acid (EDTA) and either
used in experiments or replated (one third) in 25-cm
2
culture flasks and expanded.
Immunological characterization of rMSCs
rMSCs (passage P1–P2) were detached by trypsiniza-
tion, collected in fluorescence-activated cell sorting
(FACS) tubes (10
6 cells in each tube) and centrifuged
at 1,000 rpm for 10 min. Then, cells were decanted,
washed with dilution buffer containing 3% FBS and
0.01% sodium azide diluted in phosphate-buffered
saline (PBS), and centrifuged twice at 1,000 rpm for
10 min. Incubation with the following monoclonal
antibodies was performed for 30 min at 4°C: PE-CY7
antimouse/rat CD29 (clone HMb1-1; Biolegend, San
Diego, CA, USA), fluorescein isothiocyanate (FITC)
antirat/mouse CD90 (clone OX-7; Biolegend, San
Diego, CA, USA), PE antimouse/rat CD34 (clone
ICO115; Santa Cruz Biotechnology, Inc.), biotin
antirat CD45 (clone OX-1; Biolegend, San Diego,
CA, USA). In other tubes, cells were incubated with
the following appropriate isotype control reagents to
estimate the nonspecific binding of target primary
antibodies to cell surface antigens: isotype-matching
IgG-FITC, IgG-PE/Cy7 (Biolegend, San Diego, CA,
USA), IgG-PE (R&D Systems, Minneapolis, MN,
USA). In another single tube, cells were incubated
only with PerCP–streptavidin (BD Pharmigen, Ger-
many) without adding the primary antibody conjugated
with biotin. After incubation, cells were centrifuged,
decanted, and resuspended in dilution buffer three
times. Analysis was performed on a flow cytometer
(BD FACScanto™ FlowCytometer, BD Biosciences,
San Jose, CA, USA) after the establishment of gating
windows for forward light scatter and side scatter and
nonspecific bindings. Data were analyzed using FACS
Diva software. See Fig. S1 in Supplementary Material.
Differentiation of rMSCs
rMSCs were analyzed for their capacity to differen-
tiate toward osteogenic, adipogenic, and chondro-
genic lineages using specific protocols. rMSCs
cultured in culture medium without any differentiat-
ing agents were used as a control.
Osteogenic differentiation rMSCs were seeded at
approximately 3,500 cells per square centimeter on
culture dishes in a culture medium composed of
α-MEM supplemented with 10% defined FBS (lot.
APC20787; Hyclone, Logan, UT, USA) until subcon-
fluence occurred. After this period, cells were grown
in culture medium alone or in osteogenic medium (OS
medium) consisting of the same culture medium with
the addition of the following supplements: dexameth-
asone 100 nM, b-glycerophosphate 10 mM and
ascorbic phosphate acid 0.05 mM. Osteogenic differ-
entiation was evaluated by alizarin red staining to
visualize calcium deposits. For a quantitative assess-
ment of osteogenic differentiation at day 14 and at
day 28 after induction, staining was quantified
spectrophotometrically (A405) after solubilization with
5% sodium dodecyl sulfate in 0.5 N HCl.
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approximately 15,000 cells per square centimeter on
culture dishes in a culture medium composed of
α-MEM supplemented with 10% defined FBS. After
24 h, cells were induced by treatment with adipogenic
induction medium, consisting of α-MEM plus 10%
defined FBS supplemented with glucose 4.5 g/l,
insulin 10 μg/ml, isobutylmethylxanthine 500 μM,
indomethacin 100 μM, and dexamethasone 1 μM.
Cells treated with α-MEM (4.5 g/l glucose) plus 10%
defined FBS without other supplements represented
the controls. Adipogenic differentiation was evaluated
by the accumulation of lipid vacuoles using Oil Red
O staining. For a quantitative assessment of adipo-
genic differentiation at day 14 and at day 28 after
induction, staining was quantified spectrophotometri-
cally (A490) after solubilization with isopropanol.
Chondrogenic differentiation Chondrogenic differen-
tiation was induced in cells grown as a pellet in 15-ml
tubes, at approximately 250,000 cells per tube, in
chondrogenic medium for about 6 weeks. Chondro-
genic medium consists of α-MEM plus 15% defined
FBS with the addition of pyruvate 1 mM, dexameth-
asone 100 nM, ascorbic-2-phosphate acid 37.5 μg/ml,
and transforming growth factor β3 10 ng/ml. Sections
of paraffin-embedded pellets were stained with
hematoxylin–eosin and safranin O to evaluate the
formation of cartilaginous structures and the presence
of proteoglycans and glycosaminoglycans. For a
quantitative assessment of chondrogenic differentia-
tion at day 14 and at day 28 after induction, pellets
were digested for 16 h at 60°C with 250µg/ml papain,
and sulfated glycosaminoglycans (sGAG) were quan-
tified spectrophotometrically (A530) using the 1.9-
dimethyl-methylene blue method. The amount of
sGAG was normalized with respect to DNA content,
measured by Hoechst staining, and expressed as
microgram sGAG per microgram DNA (Liebman
and Goldberg 2001).
Statistical analysis Experiments for quantitative
assessmentofosteogenic,adipogenic,andchondrogenic
differentiation were performed in triplicate. Statistical
analysis was performed using the one-way ANOVA
test and Tukey’s multiple-comparison test as a posttest
with the statistical package Graph Pad Prism (Version
3.03 for Windows, GraphPad Software, San Diego, CA,
USA, www.graphpad.com).
Cytogenetic, micronuclei analysis, and molecular
karyotyping
To obtain chromosome preparations, actively dividing
cells from 70% to 80% confluent culture flasks were
treated with colcemid (10µg/ml) at a concentration of
100 μl/ml for 4 h and 30 min at 37°C. After exposure
to mitotic arrestant, the cells were dislodged from the
flask using trypsin–EDTA 1× in PBS (Biosera) for
7 min at 37°C, collected into 15-ml centrifuge tubes,
and pelleted by centrifugation at 2,000 rpm for 6 min.
The supernatant was discarded, and the pellet was
suspended in 9 ml of 0.56% KCl for 12 min at 37°C.
Following incubation in the hypotonic, 1 ml of
freshly prepared fixative (methyl alcohol–glacial
acetic acid, 3:1) was added, and the suspension was
centrifuged at 2,000 rpm for 6 min. The pelleted cells
w e r es u s p e n d e di n5m lo ff r e s hf i x a t i v ef o r1 5m i na t
room temperature, and the fixative was later changed.
About three drops of the cell suspension were
d r o p p e do n t oc o l d ,d r ys l i d e st i l t e da ta na n g l eo f
30° and air-dried. This procedure allowed metaphase
spreads in which the two chromatids of each
chromosome lay close together and were relatively
long (Fig. 1). Slides were stored at room temperature
in a dry place and then stained for karyotype
analysis.
For QFQ banding by fluorescence using quina-
crine, the prepared slides were stained by immersion
in a solution of quinacrine mustard (5 mg/ml of
distilled water; Sigma) for 1 min at room temperature,
washed for 1 min, and wet-mounted in McIlvaine’s
buffer under a coverslip. Metaphase chromosomes
were observed with a Leica DMR fluorescent micro-
scope, using a UV lamp, a 515-nm barrier filter, an
H3 exciter filter (420–490 nm), and an immersion
×100 objective. Images from the well-spread meta-
phases were captured using a CCD camera with
dedicated software (Tesi Imaging, Italy). The karyo-
type was described according to the guidelines of the
Committee for Standardized Karyotype of Rattus
norvegicus (Committee for a Standardized Karyotype
of Rattus Norvegicus 1973). At least 50 metaphases
were analyzed for each passage in vitro. A chromo-
somal aberration was defined as clonal when at least
two metaphases showed the same aberration; if the
abnormality was a missing chromosome, the same
change had to be present in at least three cells to be
accepted as clonal.
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counted. Micronuclei are very small nuclei or bubbles
from the nucleus that remain in the cytoplasm of the
cell; they arise whenever a chromosome or a fragment
of chromosome is not incorporated into one of the
daughter nuclei during cell division. High frequencies
of micronuclei indicate an anomaly of mitotic
segregation.
Molecular karyotyping was performed through
array-CGH with the Agilent kit (Rat Genome CGH
Microarray 105A, Agilent Technologies) according to
the manufacturer’s instructions. The array-CGH plat-
form is a 60-mer oligonucleotide-based microarray, a
high-resolution tool for genome-wide DNA copy
number variation profiling without amplification or
complexity reduction. It has 97,000+ coding and
noncoding rat-specific sequences and 19.1 KB overall
median probe spacing (11.3 KB in Refseq genes). The
genetic situation of rMSCs from rat 8 was tested
before culturing (fresh sample), just after cell isola-
tion, and after 15 days’ culture before passaging
(defined as P0); rMSCs from rat 1 were evaluated
after prolonged in vitro culture, at P4 and P24. Rat
genomic DNA reference was composed of a pool of
DNA extracted from cells isolated from five different
Sprague-Dawley control rats after 15 days’ culture
before passaging. Control cell cultures were per-
formed in 20% FBS α-MEM medium.
The arrays were scanned at 2-μm resolution using
Agilent microarray scanner and analyzed using
feature extraction v10.5 and DNA analytics v4.0
software. For each spot, log2 ratios of the Cy3-
labeled test sample vs. Cy5 reference sample were
computed and normalized by DNA Analytics 4.0
software. The Aberration Detection Method 2
(ADM2) algorithm was used to compute and assist
the identification of aberrations for a given sample. In
brief, ADM2 algorithm uses an iterative procedures to
identify all genomic regions for which the weighted
average of the measured log2 ratios from probes in
Fig. 1 Selected metaphase
Q-banded spreads with
chromosomal anomalies. a
Trisomy for chromosome 6,
[43,XX,+6]; b functional
trisomy for chromosome 6,
[42,XX,der(6;6)]; c
trisomy for chromosome
13, [43,XX,+13]. The
chromosomal anomalies are
indicated by arrows
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more than a given threshold. The ADM2 algorithm
was applied with a threshold of 5, minimum absolute
average log2 ratio in called intervals of 0.5, and
minimum of three probes. So the putative chromo-
some copy number changes were defined by intervals
of three or more adjacent probes and were considered
as duplicated or deleted when result exceeded the
±0.50 range.
Results
rMSC cultures
According to the criteria proposed in the definition of
MSCs (Dominici et al. 2006), the MSCs isolated in
our laboratory from rat bone marrow and used in our
experiments, are: (a) plastic adherent and capable of
extensive proliferation when maintained in standard
culture conditions; (b) positive for several antigens
such us CD29, CD90, and CD105 and lacking in the
expression of hematopoietic surface molecules CD34
and CD45 (Fig. S1 in Supplementary Material); (c)
able to differentiate into osteogenic, adipogenic, and
chondrogenic lineages under specific in vitro differ-
entiating conditions (Fig. 2). rMSCs were treated with
differentiation media for 28 days, and during this
period their differentiation capacity was quantitatively
assessed by specific methods (see “Material and
methods”).
In our culture conditions (culture medium in the
absence of any differentiative agents), morphological
changes were also observed. At P0 and P1, rMSCs
were morphologically heterogenous. From P2, rMSCs
became morphologically homogenous, had a
fibroblast-like phenotype, and showed a trend to
become smaller with increasing passages (from P16
to forward passages). At P48, they lost their
fibroblast-like phenotype (Fig. 3) but still maintained
their capacity to actively divide.
rMSCs were kept in culture from P0 to P48 that
corresponded to about 35 weeks (238 days) of culture.
Cells were passaged 1:3 after reaching 80–90% of
confluence. The time required to achieve 80–90% of
confluence differed depending on the passage num-
ber: 2 weeks for P0 and P1, 1 week for passages
between P2 and P15, and only 3–4 days for P16 and
forward passages. These data referred to cells cultured
in α-MEM (or DMEM) containing 20% of FBS. The
times required for cells cultured with 10% of FBS
were double those obtained in 20% FBS. The
differentiation capacity was quantitatively assessed
at passages 1, 4, 8, 16, 24, and 48 as shown in Fig. 4.
Osteogenic capacity (Fig. 4a) was increased at 28 days
for almost all the passages analyzed. Adipogenic
differentiation (Fig. 4b) was observed in most of the
passages examined, but it was enhanced after 14 days
of treatment. Chondrogenic differentiation (Fig. 4c)
after 28 days of treatment was more evident at
passages 8, 24, and 48.
Cultured rMSCs karyotype
The modal number of chromosomes (i.e., those most
highly represented in a population that has several
aneuploid cell clones) tended to deviate from the
normal karyotype 42,XX (Table 1), starting from
early passages (already from P1) while at P0, both at
one and at 15 days after isolation, regardless of the
culture conditions, the normal modal number of
chromosomes was, in general, conserved (Table 2).
The percentages of cells with micronuclei and
metaphases with random loss (i.e., signs of genomic
instability) were widely variable, although the com-
mon trend was towards a reduction with increasing in
vitro passages. These changes appeared to be inde-
pendent of the culture conditions (Table 3). Aneuploid
cells increased with increasing passages, i.e., for
animal 1 at P48, almost all cells (96.4%) were
aneuploid with at least one clonal numeric aberration
(Table 1 and Fig. 5a). In addition, a slight correlation
between the percentages of cells with a clonal
chromosomal anomaly and the culture media
emerged, as demonstrated for two animals in
Fig. 5b, c where in both cases α-MEM was found
to be the most stabilizing medium. Regarding the
anomalies, the trisomies were more frequent than the
monosomies. In particular, the monosomy of chro-
mosome 20 recurred in two animals. The trisomies
involved ten different chromosomes, but only the 13 s
and, to a minor degree, the 6 s were frequently
observed in different animals (Table 1 and Fig. 1). In
order to assess if this bizarre in vitro behavior was a
prerogative or not of rMSCs, we monitored, in a
similar way, the karyotype of hMSCs. We never
found any clonal numeric aberration nor clonal
structural aberration until passage 16 (data not
1030 D. Foudah et al.shown), confirming the general chromosomal stability
reported in literature for these cells (Aguilar et al.
2007; Bernardo et al. 2007; Zhang et al. 2007).
Finally, we performed molecular karyotyping by
means of array-CGH on rMSCs. We analyzed the
genomic status of rMSCs through the competition
with a genomic pool of rMSCs after 15 days of
culture, from five different rats, in order to have as
suitable as possible a reference for our array-CGH
experiments. The array contained a library of probes
selected from the rat genome database. We analyzed
the genomic status of a control Sprague-Dawley rat
(rat 8): (1) immediately after cell isolation (fresh
sample) and (2) after 15 days postisolation cell
culture; and of rat 1 (in addition to conventional
karyotyping): (3) at culture passage P4 and (4) at
culture passage P24; the data are summarized in
Fig. 6 and in Table S1 in Supplementary Material. We
identified 37 copy number variants (CNVs), 19 gains
and 18 losses, covering at least 120 Mb, with sizes
ranging from 12.8 kb (an heterozygous loss of rat 1
P4 and P24) to more than 100 Mb for chromosome 13
Fig. 2 rMSC differentiation.
Osteogenic differentiation.
Alizarin red staining of
rMSCs cultured for 28 days
in α-MEM supplemented
with 10% defined FBS (con-
trol, a)o ri nO Sm e d i u m .( b)
Adipogenic differentiation.
Oil Red O staining of rMSCs
cultured for 28 days in α-
MEM (4.5 g/l glucose)
supplemented with 10%
defined FBS (control, c)o r
in adipogenic induction
medium (d). Bars 50 μm.
Chondrogenic differentia-
tion. Safranin O staining of
paraffin-embedded sections
o fr M S C sc u l t u r e di np e l l e t s
for 6 weeks in α-MEM
supplemented with 15%
defined FBS (control, e)o r
with chondrogenic induction
medium (f). Bars 50 μm
Unstable karyotype of cultured rat MSCs 1031trisomy of rat 1 at P24, still identified by conventional
karyotyping. For rat 8, we observed a total of 14 gains
versus ten losses, while for rat 1, 11 gains and 12
losses were detected. Eleven CNVs identified in our
work were recently identified in a rat genome-wide
study by two other microarray platforms (Guryev et
al. 2008), and five out of these 11 were also detected
in both rats analyzed. Notably, we found the presence
of an instable region of 381 Kb on chromosome 6q33
observing 23 consecutive probes, alternately as gain
or loss (see Table S1 in Supplementary Material).
Another CNV, a gain of 795.8 kb in Xq35, in the
same CNV region annotated by Guryev et al. 2008,
was detected both in rat 1 and in rat 8 but, in the
latter, it was evidenced only after cell isolation (in a
fresh sample) while, after 15 days postisolation cell
culture, it was absent, showing again genomic
instability when these cells were cultured in vitro
(see Table S1 in Supplementary Material for other
examples).
Discussion
This is the first time, to our knowledge, that such a
thorough and complete study on the genomic
stability of rMSCs has been carried out, by means
of cytogenetic characterization and molecular kar-
yotyping. We used both a conventional, traditional
cytogenetic technique and an array-CGH platform,
in order to have the opportunity to observe also
balanced structural abnormalities and to identify
Fig. 3 rMSC cultures. rMSC cultures displayed different mor-
phology according to the passage number: at P1 rMSC cultures
were still heterogenous; at P2, they became homogenous,
characterized by the presence of cells with a fibroblast-like
phenotype; at P16, they were already morphologically homoge-
nous, but cells seemed to be smaller in size with respect to
previous passages; at P48, cells lost their fibroblastic-like shape,
appearing more rounded and forming a homogenous monolayer
film. Bars 100 μm
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more advanced techniques are not able to do. We
demonstrated that, irrespective of culture condi-
tions, rMSCs manifested a markedly aneuploid
karyotype and a chromosomal instability in all the
passages we analyzed and that they are anything
but stable during in vitro culture.
Despite their chromosomal instability, rMSC dif-
ferentiation capability is not affected. In fact, rMSCs
are able to differentiate into mesengenic lineages in
the culture passages in which genomic instability has
been demonstrated. This finding does not exclude that
other biological properties of rMSCs can be modified
consequently to the altered genomic stability. Regard-
ing the maintenance of these properties, similar
findings are reported in literature for adult and
embryonic mouse neural stem cells (Goffredo et al.
2008; Spiliotopoulos et al. 2009).
Several studies on MSCs from different sources
have highlighted how genomic instability could lead
to spontaneous immortalization and malignant trans-
formation (see Table S2 in Supplementary Material
for a literature review). In particular, spontaneous
transformation of MSCs after in vitro culture expan-
sion has been reported in human adipose-derived
MSCs (Rubio et al. 2005; Wang et al. 2005) and in
mouse bone-marrow-derived MSCs (Miura et al.
2006; Zhou et al. 2006; Aguilar et al. 2007; Tolar et
al. 2007). Only two studies to date have reported on
the chromosomal status of cultured rMSCs (Zhou et
al. 2006; Furlani et al. 2009). The former, by GTG
banding at P6, revealed that the majority of these cells
maintained the normal number of 42 rat chromosomes
with no translocations, although three out of the 50
cells analyzed were tetraploid (84 chromosomes). The
latter, on the contrary, is completely in agreement
with our results as the authors demonstrated that
rMSCs, cultured under standard conditions, could
u n d e r g ot r a n s f o r m a t i o ni nt h ee a r l yp a s s a g e s( a t
P3), and these observations were derived from a
simple counting of chromosome numbers following
Giemsa staining. The data we collected were derived
from a more detailed karyotype analysis on rMSCs
from different animals, in vitro expanded under
four culture conditions, and monitored at several
passages in culture; furthermore, we also had the
opportunity to compare the data obtained by array-
CGH analysis, a technique for high-resolution
genomic studies, on fresh rMSCs (immediately
after cell isolation) and after culture expansion,
derived from the same animal. Our results indicate
that in vitro cultured rMSCs showed a progressive
chromosomal instability associated with an increased
rate of proliferation.
As many studies have evidenced the close
correlation between chromosome instability, spon-
taneous transformation, and cancer initiation (Rubio
et al. 2005;W a n ge ta l .2005; Zhou et al. 2006;
Fig. 4 rMSC differentiation quantitative assessment. rMSC at
different passages were treated for a osteogenic differentiation
(osteo); b adipogenic differentiation (adipo); c chondrogenic
differentiation (chondro) for 14 or 28 days, and quantitative
assessment of differentiation was performed. For each treat-
ment, rMSCs cultured in culture medium without any differen-
tiating agents were used as a control (ct). Experiments were
performed in triplicate and results are expressed as mean±SD.
*p<0.05: **p<0.01
Unstable karyotype of cultured rat MSCs 1033Table 1 Karyotype in vitro evolution of rMSCs from four rats cultured in four different media
Medium Culture
passage
Animal %
normal
% with clonal numeric aberration % with structural aberration % with random
loss/gain
αMEM
20% FBS
1° 3 67.3 6.1 (41,XX,−20) 0 26.6
4 51.7 5 (41,XX,−20) 0 43.3
4° 1 67.2 8.2 (43~44,XX,+13,+13,cp[4]) 0 24.6
4 77.8 0 0 22.2
8° 1 9.2 66.7 (43~44,XX,+13,+13,cp[33]) 0 24.1
2 67.5 15 (43~44,XX,+13,+13,cp[8]) 0 17.5
3 56.8 27 (43,XX,+13) 0 16.2
47 6 0 0 2 4
16° 1 1.7 54.2 (43,XX,+13) 37.3 (42,XX,der(2;15)) 6.8
2 28 40 (43~44,XX,+11,+13,cp[20]) 0 32
3 29.6 42.6 (43,XX,+10,+13,cp[23]) 1.8 (44,XX,+13,t(3;11),der3p);1.8
(42,XX,+13,−16,t(3;4))
24.2
4 69 5.8 (41,XX,−20) 0 25.2
24° 1 0 91.7 (43~44,XX,+13,+13,cp[46]) 2.7 (42,XX,der(2;15)) 5.6
3 0 92.2 (43,XX,+13) 0 7.8
4 3.8 26.4 (41~85,XXXX,−20,+10,+13,
cp[14])
0 69.8
48° 1 1.8 96.4 (43~44,XX,+13,+13,cp[48]) 0 1.8
αMEM
10% FBS
1° 3 60 8.2 (41,XX,−20) 2 (42,XX,der(6;6)) 29.8
47 6 0 0 2 4
4° 3 73.6 11.1 (43,XX,+13) 0 15.3
4 66.8 0 0 33.2
8° 3 30.6 27 (43,XX,+13) 9.4 (42,XX,der(6;6)) 33
4 60 6.65 (43,XX,+18) 6.65 (43,XX,+mar) 26.7
16° 3 0 5.6 (41,XX,der(6;6),-20) 92.6 (42,XX,der(6;6)) 1.8
4 0 45.7 (79~88,XXXX,−20,+4,+5,+6,
+7,+10,+11,+12,cp[16])
37.1 (85~87,XXXX,+mar1,+mar2,
cp[13])
17.2
24° 3 0 15.7 (43~46,XX,der(6;6), +3,+6,
+12,+13, cp[8])
80.4 (42,XX,der(6;6)) 3.9
DMEM
20% FBS
1° 4 80.4 0 0 19.6
4° 4 78.3 4.3 (43,XX,+13) 0 17.4
8° 4 50 0 10 (42,XX,1dicen) 40
16° 4 1.8 0 76 (42,XX,5p+) 22.2
DMEM
10% FBS
1° 3 69 10.3 (41,XX,−20) 1.7 (42,XX,der(5;18)) 19
4 33.3 0 0 66.7
4° 3 79.5 0 0 20.5
4 6.7 76.6 (43~44,XX,+6,+13,cp[23]) 3.3 (45,XX,+11,+13,+14,1dicen) 13.4
8° 3 32.4 38.2 (43,XX,+6,+7,cp[26]) 13.2 (42,XX,2p+) 16.2
4 2 68 (43~48,XX,+3,+7,+12,+13,+14,
cp[34])
03 0
16° 4 0 73.2 (46~48,XX,+3,+4,+6,+7,+12,
+13,+14,cp[38])
0 26.8
24° 3 2 92 (43~44,XX,+3,+7,+13,cp[46]) 0 6
The percentages refer to the total number of metaphases analyzed; at least 50 metaphases were analyzed for each passage. For some culture
passages, a great karyotypic heterogeneity was observed and composite karyotypes (cp) were created. These cp contained all clonally observed
abnormalities and gave the range of chromosome numbers in the cells containing the clonal aberrations. The number of cells in which the
clonal changes were observed was given in square brackets after the karyotype
1034 D. Foudah et al.Aguilar et al. 2007; Tolar et al. 2007), we searched
the resulting abnormal karyotypic regions in silico
for genes that might be important for cell cycle
regulation. Interestingly, on chromosome 13, which
was the most frequently involved in karyotype
aberrations and in rat 1 is even present in triplicate,
was mapped the predicted RGD1561440 (http://
www.ensembl.org/Rattus_norvegicus/), this being
similar to the human nemo-like kinase gene (NLK)
and necessary for the differentiation of bone marrow
stromal cells. The human NLK negatively regulates
the Wnt/beta-catenin signaling pathway and the Myb
transcription factor (see The UniProt Consortium:
http://www.uniprot.org/uniprot/Q9UBE8). More-
over, on chromosome 13, many other genes are
mapped which are involved in cell cycle regulation
and in malignant transformation (e.g., oncogenes
Abl2, Bcl2, Mapkapk2; http://www.ensembl.org/
Rattus_norvegicus/), suggesting that aberrations of
chromosome 13 may lead to changes in the biolog-
ical properties of rMSCs which are important for
their normal functioning and which could predispose
them to malignant transformation.
Similarly, for chromosome 6, which was found to
be involved in a functional trisomy, the der(6;6), both
by conventional karyotyping and by array-CGH
analysis, real outbreak of gain and loss of CNVs
was found to have taken place. It is interesting to note
that one common aberration detected in a rat model of
endometrial adenocarcinoma is a gain/amplification
affecting the proximal part of this chromosome
(RNO6) including three cancer-related genes: Ddx1,
Rrm2, and Mycn (Adamovic et al. 2005). Mouse
neuroblastoma myc-related oncogene 1 (Nmyc1)
possesses transcription factor activity that plays a role
in cell cycle regulation. MYCN is known to be
Table 2 Karyotype of rMSCs from control rats at P0 cultured in four different media
Medium Days after
isolation
Animal % normal % with clonal
numeric aberration
% with structural
aberration
% with random
loss/gain
αMEM 20% FBS 1 5.09 96 0 0 4/0
6.09 88 0 0 12/0
7.09 85.3 0 0 11.8/2.9
8.09 82.4 0 0 17.6/0
9.09 82.4 0 0 17.6/0
10.09 86.3 0 0 11.8/1.9
15 5 44.4 0 0 48.1/7.5
6 81.5 0 0 14.8/3.7
7 78.4 0 0 19.6/2
5.09 85 0 0 7.5/7.5
6.09 76 0 0 22/2
7.09 86.8 0 0 7.5/5.7
8.09 76.5 0 0 23.5/0
9.09 63.7 0 0 33.3/3
10.09 78 0 0 16/6
α-MEM 10% FBS 15 5 75 0 0 25/0
6 72.5 0 0 25.2/2
7 52.9 0 0 43.1/4
DMEM 20% FBS 15 5 69 0 0 27.6/3.4
6 48.1 0 0 50/1.9
7 72.5 0 0 25.4/2.1
DMEM 10% FBS 15 5 83.3 0 0 16.7/0
6 44.2 5.8 (41,X); 5.8 (41,XX,-20) 0 44.2/0
7 68 0 2 (43,XX,+mar)
a 20/10
aNot clonal
Unstable karyotype of cultured rat MSCs 1035Fig. 5 Percentage of metaphases with clonal chromosomal
anomalies (both aneuploidies and structural aberrations) versus
passage progression. a Rats 1–2–3–4i nα-MEM 20%FBS; b
rat 3 in α-MEM 20% FBS, α-MEM 10%FBS, DMEM 10%
FBS; c Rat 4 in all the culture conditions used in this study
Table 3 Micronuclei counting of rMSCs of four rats cultured
in four different media
Animal Medium Culture
passage
% normal
nuclei
%
micronuclei
1 αMEM 20% FBS 4° 54.5 45.5
8° 80.4 19.6
16° 86.8 13.2
24° 88 12
48° 91.2 8.8
2 αMEM 20% FBS 4° 69.7 30.3
8° 85 15
1° 83.4 16.6
8° 65.8 34.2
16° 30.6 60.4
24° 49.3 50.7
3 αMEM 10% FBS 1° 80.7 –
5° 43.9 56.1
8° 29.4 70.6
16° 19.8 80.2
24° 30.2 69.8
DMEM 10% FBS 1° 82.2 17.8
5° 64.2 35.8
8° 76 24
24° 66.9 33.1
4 αMEM 20% FBS 1° 41.4 58.6
4° 31.1 68.9
8° 38.3 61.7
16° 59 41
24° 47.2 52.8
αMEM 10% FBS 1° 34.3 65.7
4° 27.1 72.9
8° 44.4 55.6
16° 37.8 62.2
DMEM 20% FBS 1° 45.8 54.2
4° 63.1 36.9
8° 46.1 53.9
16° 70.5 29.5
DMEM 10% FBS 1° 38.6 61.4
4° 44.1 55.9
8° 49.4 50.6
16° 66.4 33.6
At least 1,000 nuclei were analyzed for each passage
1036 D. Foudah et al.amplified in human neuroblastomas, in several other
human tumors (Brodeur et al. 1984; Rubie et al.
1997), and in mouse medulloblastomas (Shakhova et
al. 2006). Similarly, increased c-myc expression, the
most famous member of the myc-family, has recently
been described in mouse bone marrow MSCs and in
human adipose MSCs; in both cases, continuous
passaging led MSCs to spontaneous immortalization
and transformation into malignant cells, suggesting a
role for this gene in these processes. So, we could
speculate that there is a possible risk of neoplastic
transformation where there is a gain/amplification of
rat chromosome 6.
Finally, our results support the idea that there is a
considerable risk for long-term rMSC cultures as the
genomic instability has been amply demonstrated.
Fig. 6 Chromosomal distribution of CNV regions detected by
array comparative genomic hybridization (array-CGH) on
rMSCs of a rat 1 at P4 (top) and P24 (bottom); b rat 8 freshly
isolated cells (top) and 2 weeks culture (bottom). Colors
represent the type of chromosomal aberration: red (region with
gain compared to reference); green (region with loss compared
to reference). See Table S1 in Supplementary material and the
text for more details
Unstable karyotype of cultured rat MSCs 1037Despite the fact that the risk of neoplastic transfor-
mation associated with this genomic instability needs
to be further addressed and considering the apparent
genomic stability reported for in vitro cultured
hMSCs (see Table S2 in Supplementary Material),
our findings underline the fact that rMSCs may not in
fact be a good model for effectively exploring the full
clinical therapeutic potential of hMSCs.
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